Skip to main content
Clinical Trials/NCT01647698
NCT01647698
Active, Not Recruiting
N/A

Beyond the Physical: Enhancing Psychosocial Functioning in Parkinson's Disease

Gail Eskes1 site in 1 country30 target enrollmentOctober 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
Gail Eskes
Enrollment
30
Locations
1
Primary Endpoint
Change in working memory function between baseline and 10 weeks post training onset
Status
Active, Not Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This project will investigate the feasibility and preliminary effectiveness of an intensive and focused working memory training program for patients in the early stages of PD receiving dopaminergic therapy. The investigators hypothesize that working memory training will be an effective method of improving working memory and related cognitive and behavioural functions in PD patients.

Detailed Description

Parkinson's disease (PD) is not an exclusively motor disease; more than half of individuals with PD experience cognitive impairment even in the early stages of the disease and many develop dementia as the disease progresses. As a result, attention, memory, planning and organizational skills can be affected, interfering with everyday functioning (e.g. shopping, managing finances, job skills). Thus, interventions to improve cognitive abilities are needed to enhance psychosocial function and overall quality of life. Some cognitive deficits, such as problems with working memory, are apparent even in the early stages of the disease. Working memory (WM) is the ability to actively maintain and manipulate information in one's mind and is needed for many complex tasks such as learning, communication and problem-solving . Individuals with PD often show deficits in both WM maintenance (e.g., holding a phone number in mind to make a call) and manipulation (e.g.,mental calculation at the grocery store checkout) skills, depending upon the stage of the disease and progression of damage to frontal-subcortical circuits. Attempts to identify pharmacological agents that ameliorate cognitive dysfunction have been largely unsuccessful or associated with undesirable side effects (e.g. Vale, 2009). The investigators propose that specific cognitive training to improve WM could provide direct benefit to psychosocial function of PD patients; it could potentially enhance any positive benefits or reduce the negative effects of pharmacological treatment without an added risk of side effects as well. Promising interventions focused on intensive and direct WM training are emerging and have been shown to generalize to other cognitive domains, such as fluid intelligence. Cognitive training has been successful in patients with traumatic brain injury, who also show WM deficits as a result of damage to frontal-subcortical circuits. In addition, successful WM training is associated with changes in dopamine receptor density as well as changes in patterns of neural activity in task-relevant areas of the brain. To date, a limited number of small group studies provide preliminary evidence that some aspects of cognitive function can be enhanced by training in PD patients also receiving dopaminergic therapy, although few use control groups to account for potential repeated testing practice effects.

Registry
clinicaltrials.gov
Start Date
October 2013
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Gail Eskes
Responsible Party
Sponsor Investigator
Principal Investigator

Gail Eskes

Dr. Gail Eskes

Nova Scotia Health Authority

Eligibility Criteria

Inclusion Criteria

  • clinical diagnosis of idiopathic Parkinson's disease
  • self-reported concerns about their working memory, or working memory deficits that were identified by a clinical examination
  • be classified as Hohn \& Yahr Stage 1 or 2
  • be receiving a stable dose of dopaminergic therapy

Exclusion Criteria

  • presence of dementia or other significant neurological or psychiatric conditions, as determined by clinical history
  • Classification as Hohm \& Yahr Stage 3 or 4
  • Not on a stable dos of dopaminergic therapy

Outcomes

Primary Outcomes

Change in working memory function between baseline and 10 weeks post training onset

Time Frame: 10 weeks post training onset

Baseline Working memory function

Time Frame: baseline

Working memory will be measured using the operation span task, the symmetry span task and the Sternberg memory scanning tasks. Operation span - This is a dual-task in which participants complete mathematical reasoning (e.g. solving a mathematical equation) while using short-term verbal memory to remember words. Symmetry span: This is a dual task in which participants discriminate about the symmetry of visual stimuli while using short-term spatial memory to remember the locations of stimuli. Sternberg memory scanning task - number memory test

Change in working memory function between baseline and 5 weeks post training onset

Time Frame: 5 weeks post training onset

Change in working memory function between baseline and 22 weeks post training onset

Time Frame: 22 weeks post training onset

Secondary Outcomes

  • change in fluid intelligence between baseline and 5 weeks post training onset(5 weeks post training onset)
  • Baseline Executive functioning(Baseline)
  • Change in executive functioning between baseline and 5 weeks post training onset(5 weeks post training onset)
  • Change in fluid intelligence between baseline and 22 weeks post training onset(22 weeks post training onset)
  • Change in executive functioning between baseline and 10 weeks post training onset(10 weeks post training onset)
  • Baseline fluid intelligence(Baseline)
  • Change in fluid intelligence between baseline and 10 weeks post training onset(10 weeks post training onset)
  • Change in executive function between baseline and 22 weeks post training onset(22 weeks post training onset)

Study Sites (1)

Loading locations...

Similar Trials